A phase II trial of cisplatin and prolonged administration of oral etoposide in extensive-stage small cell lung cancer
Open Access
- 15 January 1992
- Vol. 69 (2) , 370-375
- https://doi.org/10.1002/1097-0142(19920115)69:2<370::aid-cncr2820690217>3.0.co;2-e
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Current status of etoposide in the management of small cell lung cancerCancer, 1991
- Etoposide kinetics in patients with obstructive jaundice.Journal of Clinical Oncology, 1990
- New drugs in the management of small cell lung cancerLung Cancer, 1989
- Mechanism of Action of Antitumor Drug Etoposide: A ReviewJNCI Journal of the National Cancer Institute, 1988
- In vitro pharmacodynamic evaluation of VP-16-213 and implications for chemotherapyCancer Chemotherapy and Pharmacology, 1987
- Small cell carcinoma of the lungCritical Reviews in Oncology/Hematology, 1986
- Etoposide (VP-16) in the treatment of lung cancerCancer Treatment Reviews, 1983
- Small cell carcinoma of the lungBlood, 1980
- Evaluation of response criteria in advanced lung cancerCancer, 1979
- Cell cycle stage-dependent induction of G2 phase arrest by different antitumor agentsPublished by Elsevier ,1978